Bio-Integrative, Fiber-Reinforced Kneebar for Treating Subchondral Insufficiency of the Knee
Launched by STANFORD UNIVERSITY · Nov 14, 2023
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to treat knee pain caused by a condition called subchondral insufficiency fracture, which involves problems with the bone under the cartilage in the knee. Researchers want to see if using special implants called OSSIOfiber® Trimmable Fixation Nails can help improve both how patients feel and what doctors see on imaging tests. These nails are designed to help keep the bones in place while the knee heals, and they are used according to approved medical guidelines.
To join this study, participants should be between the ages of 65 and 74 and have experienced knee pain for at least three months. They also need to be candidates for a specific knee procedure called arthroscopy, usually due to issues like a torn meniscus or mechanical problems in the knee. However, individuals who smoke, have certain health conditions like diabetes, or are currently pregnant cannot participate. If someone decides to take part in this trial, they can expect to receive the new treatment and be monitored closely for their progress and recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Has had knee pain in study knee lasting at least 3 months
- • 2. Candidate for knee arthroscopy due to meniscal tear, loose body, unstable articular cartilage or mechanical symptoms.
- Exclusion Criteria:
- • 1. Current tobacco use or has quit within 3 months of study enrolment.
- • 2. Substance abuse history.
- • 3. Diabetes mellitus, HbA1c\>8
- • 4. High surgical risk due to pre-existing conditions.
- • 5. Currently pregnant or has plans to become pregnant prior to surgery.
- • 6. Active infection or history of chronic infection in study knee.
- • 7. Will require concomitant procedures within study knee, including but not limited to ligament reconstruction, tendon repair, meniscus repair, microfracture, osteotomy, or osteochondral transplantation. (Meniscal tears, including chronic, are acceptable if no repair is required)
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Seth L Sherman, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported